Sale of Securities

Compass Therapeutics, Inc. Filed 2025-04-09 Acc 0000947871-25-000375

Documents 1

2025-04-11 4 Director sold 3,571,428 shares at $1.59 ($5,678,571)
2025-04-11 4 Director sold 3,571,428 shares at $1.59 ($5,678,571)
2025-04-11 SCHEDULE 13D/A Beneficial Ownership Report
2025-04-09 144 Sale of Securities
2025-04-09 144 Sale of Securities
2025-04-08 4 Gen Counsel & Corporate Sec bought 20,000 shares at $1.54 ($30,800)
2025-04-08 4 CHIEF ACCOUNTING OFFICER bought 20,000 shares at $1.42 ($28,400)

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…